DexCom, Inc. announced the new Dexcom ONE Continuous Glucose Monitoring System will launch in the United Kingdom this May. The Dexcom ONE system is an easy-to-use real-time CGM (rt-CGM) that will be more affordable and accessible for people with diabetes in the UK. Dexcom ONE is currently in review to be added to drug tariffs across the UK regions.

Dexcom ONE, a wearable sensor and transmitter, puts people firmly in control of their diabetes. By continuously monitoring glucose levels and sending real-time values wirelessly to a compatible smart device via the Dexcom ONE mobile app, the technology eliminates the need for painful fingerpricks.† The app was specially designed to be user friendly, displaying trend arrows to show the speed and direction glucose levels are heading, making in the moment treatment decisions easier. A range of customisable alerts help users avoid potentially dangerous high or low glucose events.

This news comes as the National Institute for Health and Care Excellence (NICE) announced new guidance for adults and children managing Type 1 diabetes. NICE now recommends that adults with Type 1 diabetes be offered a choice of glucose sensors, including rt-CGM, based on their individual preferences, needs, characteristics, and the functionality of the devices available. Furthermore, the guidance also recommends that all children with Type 1 diabetes be offered rt-CGM, together with education for both them and their families and/or carers on how to use their device.

This not only improves access to potentially lifesaving technology for people with diabetes, but also provides greater choice.